Belharra Therapeutics

About:

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Website: https://www.belharratx.com

Top Investors: Versant Ventures

Description:

Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomics platform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.